Summary
The insoluble 'high-molecular-weight' fraction (HMF An insoluble 'high-molecular-weight' fraction of ProtinR-treated soy protein isolate (hereinafter, HMF) is more hypocholesterolemic than the very soy protein isolate (1) (2) (3) . This rise in function is accounted for by the binding of bile acids to HMF and their fecal excre tion in larger amounts. HMF is inferior in protein-nutri tive value to soy protein isolate, one-fourth being locked upon as indigestible 'dietary fiber' in a broad sense (4) . Such proteinous 'dietary fibers' are referred to as 'resist ant proteins' which, for example, affect short-fatty acid profiles in the rat cecum (5). As for "soybean resistant proteins," it seems to be responsible for the bile acid catching and -excreting capacity of HMF. In this con nection, we found out that HMF feeding relative to ca sein feeding significantly increased the number of aber rant crypt foci (ACF) or aberrant crypts (AC) in the colon of azoxymethane-treated rats receiving dietary deoxycholate (4) . It is accepted among oncologists that the enlargement of ACF or crypt multiplicity is inti mately involved in later tumorigenesis (6) (7) (8) (9) . If this is the case, HMF feeding may result in multiplying colonic tumors, no matter how well hypercholesterolemia is improved thereby. The present investigation aims to ver ify, in relation to the variation of ACF, whether colonic tumorigenesis is actually affected by long-term HMF feeding.
MATERIALS AND METHODS
Diets. Soy protein isolate (Fujipro-R from Fuji Oil Co., Osaka, Japan) was thoroughly digested at neutral pH with an exo-type proteinase of microbial origin (Protin PC/AC from Daiwa Kasei Co., Osaka, Japan) and centrifuged to separate an insoluble fraction, followed by freeze-drying. The dried powder thus prepared is ' HMF,' with which we were supplied in bulk by the Soy Protein Research Committee of Japan. Vitamin and mineral mixtures (AIN-76 likeness) were purchased from Oriental Yeast Co., Tokyo, Japan. Other ingredients were also commercially available. The compositions of diets are shown in Table 1 . Feeding and design. Male Fischer rats, 4wk of age, were purchased from Japan Clea Co., Osaka, Japan, and housed in our animal-care facilities with a half day light/dark cycle. Fifty-five F-344 rats after 1-wk accli mation to the new environment were divided into 4 groups (n=10 or 15) and allowed free access to the respective diets shown in Table 1 . The bitterness of de oxycholic acid was so successfully masked by coating the sodium salt (DCA) with an enteric chemical "cellu lose acetate phthalate" so as not to reduce appetite . Azoxymethane (AOM) was intraperitoneally adminis tered at a dose of 15mg/kg body weight once every week for the first 3wk. Five rats of each group were ar bitrarily picked up for preneoplastic and carcinomatous observations at 12wk. Their colons were harvested after overnight starvation. The feeding of residual rats was allowed to continue for a further 27wk. The feces were collected daily from individual rats during the last week before sacrifice at 12 or 39wk. Both food intake and body weight were checked at intervals of a few days throughout the feeding period. matous (if any) lesions on the colonic mucosae at 12wk are tabulated in Table 3 . At this point in the feeding pe riod, tumor appearance was not yet recognizable. In the meantime, numerous ACF were ranked in five cate- 
DISCUSSION
There are conflicting views on whether dietary soy bean protein has a protective effect against chemically induced tumorigenesis in the intestine. McIntosh et al. (16) have reported that dairy proteins such as milk whey and casein are more effective in suppressing the development of dimethylhydrazine-induced colonic tu mors than soybean protein. As a possible explanation of the reason, they have referred to the following back ground: soybean protein relative to dairy proteins (a) stimulates cell proliferation by damaging the colonic ep ithelium, (b) brings fatty acids as well as bile acids much more into the colon by adsorption on unabsorbed ' hydrophobic' leavings, and (c) serves less as a precur sor source for the synthesis of glutathione detoxifying or eliminating mutagens. On the contrary, many of the animal studies on experimental tumorigenesis are in favor of the view that soybean products possess anti-tu morigenic effects. In most cases, however, the tumor suppressing effects were attributed to such concomi tants as isoflavonoids, protease inhibitors and phenolic compounds rather than the soybean protein itself, in which the target organ is mainly the mammary gland. In this connection, the genistein, daidzein and total isoflavonoid contents in HMF were 0.07, 0.03 and 0.11%, respectively, on a dry weight basis (information from Research Institute of Fuji Oil Co.). Upon calcula tion, the HMF diet used in this experiment includes genistein at 144mg/kg diet. According to a recent re port, the administration of genistein at 150mg/kg diet to AOM-treated rats caused a reduction in ACF of 34% at 4wk (17) . In our experiment, no significant differ ence in ACF at 12 or 39wk was observed between DCA -unfed HMF and casein groups. There is little evidence to demonstrate that isoflavones such as genistein and daidzein can actually prevent the colon from tumorige nesis in vivo. It thus seems unreasonable to consider that such isoflavonoids occurring in HMF serve as major preventive factors against colonic tumorigenesis. Previous experimental results with highly purified pro teins suggest that the lower sulfur-amino acid content in soybean protein, as compared to casein, is beneficial to the retardation of mammary tumor growth (18, 19) , while the very amino acid composition of soybean pro tein is looked upon as a disadvantage in alleviating di methyhydrazine-induced colonic tumors (16) . On the assumption that an insufficient supply of sulfur-amino acids may affect chemically-induced tumorigenesis in the colon, HMF and casein diets were supplemented with DL-methionine so as to be exactly alike in sulfur amino acid content. Additionally, it had been confirmed by a preliminary experiment a few months earlier that the 14.7% casein diet (+0.3% DL-Met) was almost equal in rat growth to the 20.6% HMF diet (+0.4% DL-Met) under AOM-untreated conditions (data not shown). The difference in protein source content between these diets (i.e., about a quarter of HMF) was interpreted as dietary fiber in a broad sense mainly consisting of an in digestible or unabsorbed 'resistant protein,' so that cel lulose powder was omitted from the HMF diet. Such a proteinous fiber left unabsorbed in the HMF digesta is far more hydrophobic than cellulose, being actually re flected in increased excretions of total lipids and steroids into the feces (Fig. 1 and sponsible for the death, the duration of feeding was bro ken off at 39wk in the fear of a further decrease in the fi nite population. ACF arising from AOM treatment are generally regarded as preneoplastic lesions, of which a part is linked to tumorigenesis (6) (7) (8) (9) . Secondary bile acids such as DCA and lithocholic acid serve as high risk factors in colonic tumorigenesis (20) (21) (22) ; neverthe less, dietary DCA brought about a substantial ACF re duction in the casein group but not in the HMF group (Tables 3 & 5) . This hinted that HMF might possibly be more tumor-promotive than casein. Can this really be so? Our current observation of visible tumors revealed that the DCA-fed HMF group ranked less in both num ber and size than the DCA-fed casein group ( 
